Javascript must be enabled to continue!
Dry eye disease among patients infected with the SARS-CoV-2 Omicron variant: a cross-sectional study
View through CrossRef
AIM: To investigate the incidence of dry eye disease (DED) and relevant risk factors among patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.
METHODS: This cross-sectional, observational analysis included 993 patients with corona virus disease 2019 (COVID-19) treated at the National Exhibition and Convention Center (Shanghai) Fangcang Shelter Hospital, from April 10 to May 26, 2022. Totally 944 uninfected control participants were recruited. All participants completed ocular surface disease index (OSDI) questionnaires, and DED symptoms were determined using OSDI scores. The demographic characteristics, length of hospital stay and in nasopharyngeal swabs were performed using questionnaires. SARS-CoV-2 Omicron variant infection was confirmed by nucleic acid-based detection in nasopharyngeal swabs using a 2019-nCoV nucleic acid detection kit. The risk factors for DED symptoms among patients with COVID-19 and control participants were determined by logistic regression analysis.
RESULTS: Patients with COVID-19 showed a higher incidence of DED than controls (64.9% vs 55.1%, P<0.001). SARS-CoV-2 infection [odds ratios (ORs) (95%CI): 1.271 (1.038, 1.556)], use of contact lenses [ORs (95%CI): 9.350 (3.676, 23.783)], history of corneal refractive surgery [ORs (95%CI): 2.047 (1.494, 2.804)], poor sleep quality [ORs (95%CI): 2.657 (2.029, 3.480)], and video display terminal (VDT) use for more than 8h per day [ORs (95%CI): 6.348 (4.720, 8.538)] were found to be risk factors for DED symptoms in patients with COVID-19 as well as controls. For patients with COVID-19, the length of hospital stay [ORs (95%CI): 1.196 (1.134, 1.262)], use of contact lenses [ORs (95%CI): 20.423 (2.680, 155.632)], history of corneal refractive surgery [ORs (95%CI): 2.166 (1.321, 3.553)], poor sleep quality [ORs (95%CI): 3.650 (2.381, 5.597)], and VDT use for more than 8h per day [ORs (95%CI): 7.740 (4.918, 12.180)] were significant risk factors for DED symptoms.
CONCLUSION: Patients with COVID-19 are more prone to develop symptomatic DED. SARS-CoV-2 infection and length of hospital stay are important risk factors for DED symptoms.
Press of International Journal of Ophthalmology (IJO Press)
Title: Dry eye disease among patients infected with the SARS-CoV-2 Omicron variant: a cross-sectional study
Description:
AIM: To investigate the incidence of dry eye disease (DED) and relevant risk factors among patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.
METHODS: This cross-sectional, observational analysis included 993 patients with corona virus disease 2019 (COVID-19) treated at the National Exhibition and Convention Center (Shanghai) Fangcang Shelter Hospital, from April 10 to May 26, 2022.
Totally 944 uninfected control participants were recruited.
All participants completed ocular surface disease index (OSDI) questionnaires, and DED symptoms were determined using OSDI scores.
The demographic characteristics, length of hospital stay and in nasopharyngeal swabs were performed using questionnaires.
SARS-CoV-2 Omicron variant infection was confirmed by nucleic acid-based detection in nasopharyngeal swabs using a 2019-nCoV nucleic acid detection kit.
The risk factors for DED symptoms among patients with COVID-19 and control participants were determined by logistic regression analysis.
RESULTS: Patients with COVID-19 showed a higher incidence of DED than controls (64.
9% vs 55.
1%, P<0.
001).
SARS-CoV-2 infection [odds ratios (ORs) (95%CI): 1.
271 (1.
038, 1.
556)], use of contact lenses [ORs (95%CI): 9.
350 (3.
676, 23.
783)], history of corneal refractive surgery [ORs (95%CI): 2.
047 (1.
494, 2.
804)], poor sleep quality [ORs (95%CI): 2.
657 (2.
029, 3.
480)], and video display terminal (VDT) use for more than 8h per day [ORs (95%CI): 6.
348 (4.
720, 8.
538)] were found to be risk factors for DED symptoms in patients with COVID-19 as well as controls.
For patients with COVID-19, the length of hospital stay [ORs (95%CI): 1.
196 (1.
134, 1.
262)], use of contact lenses [ORs (95%CI): 20.
423 (2.
680, 155.
632)], history of corneal refractive surgery [ORs (95%CI): 2.
166 (1.
321, 3.
553)], poor sleep quality [ORs (95%CI): 3.
650 (2.
381, 5.
597)], and VDT use for more than 8h per day [ORs (95%CI): 7.
740 (4.
918, 12.
180)] were significant risk factors for DED symptoms.
CONCLUSION: Patients with COVID-19 are more prone to develop symptomatic DED.
SARS-CoV-2 infection and length of hospital stay are important risk factors for DED symptoms.
Related Results
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Un manoscritto equivocato del copista santo Theophilos († 1548)
Un manoscritto equivocato del copista santo Theophilos († 1548)
<p><font size="3"><span class="A1"><span style="font-family: 'Times New Roman','serif'">ΕΝΑ ΛΑΝ&...
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein
Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein
Abstract
Emerging SARS-CoV-2 variants, especially those of concern, may have an impact on the virus’s transmissibility and pathogenicity, as well as diagnostic equi...
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Abstract
Background
SARS-CoV-2 serology tests are clinically useful to document a prior SARS-CoV-2 infection in patients with n...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found
on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus
genome is the bi...
Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
ObjectiveDespite extensive vaccination campaigns to combat the coronavirus disease (COVID-19) pandemic, variants of concern, particularly the Omicron variant (B.1.1.529 or BA.1), m...

